Back
Catalyst Pharmaceuticals Stock Price Chart
Sponsored
CPRX
Sponsored
S&P Global: Private Equity Invests $36 Billion Into What?
Read More
Buy
59
CPRX
Catalyst Pharmaceuticals
Last Price:
16.28
Seasonality Move:
7.81%
7 Day Trial
ALL ACCESS PASS
$
7
Billionaire Investors Join Forces to Fund Next Generation
Learn More- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.
Catalyst Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.2 | Buy |
20-day SMA: | 16.28 | Buy |
50-day SMA: | 14.98 | Buy |
200-day SMA: | 13.93 | Buy |
8-day EMA: | 16.12 | Buy |
20-day EMA: | 15.92 | Buy |
50-day EMA: | 15.34 | Buy |
200-day EMA: | 14.41 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.32 | Buy |
Relative Strength Index (14 RSI): | 55.66 | Buy |
Chaikin Money Flow: | 7491 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.96 - 16.76) | Buy |
Bollinger Bands (100): | (13.46 - 16) | Buy |
Catalyst Pharmaceuticals Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 16.28 while CPRX 8-day simple moving average is 16.20, which is a Buy signal.
- The stock price of CPRX is 16.28 while Catalyst Pharmaceuticals 20-day SMA is 16.28, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day simple moving average is 14.98 while CPRX share price is 16.28, making it a Buy technically.
- CPRX stock price is 16.28 and Catalyst Pharmaceuticals 200-day simple moving average is 13.93, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
59
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Buy
The current Catalyst Pharmaceuticals [CPRX] share price is $16.28. The Score for CPRX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
1.92B
Price in USD:
16.28
Share Volume:
1.16M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
18.22
52-Week Low:
11.09
Buy
59
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?
The Catalyst Pharmaceuticals stock price is 16.28 USD today. -
Will CPRX stock go up or go down?
Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Catalyst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 16.28 while CPRX 8-day exponential moving average is 16.12, which is a Buy signal.
- The stock price of CPRX is 16.28 while Catalyst Pharmaceuticals 20-day EMA is 15.92, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day exponential moving average is 15.34 while CPRX share price is 16.28, making it a Buy technically.
- CPRX stock price is 16.28 and Catalyst Pharmaceuticals 200-day simple moving average is 14.41, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.15 per share, and an increase next year of $0.45 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
- CPRX Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Catalyst Pharmaceuticals is a Buy
- Catalyst Pharmaceuticals Relative Strength Index (RSI) is 55.66, which suggest Catalyst Pharmaceuticals is overbought
- The Bollinger Bands (25) for Catalyst Pharmaceuticals is (14.96 - 16.76), which suggest Catalyst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Catalyst Pharmaceuticals is (13.46 - 16), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.